Increased glucose metabolism and insulin sensitivity in transgenic skinny mice overexpressing leptin

Diabetes

Volumn 48, Issue 9, 1999, Pages 1822-1829

  Ogawa, Yoshihiro ^a   Masuzaki, Hiroaki ^a   Hosoda, Kiminori ^a   Aizawa Abe, Megumi ^a   Suga, Junko ^a   Suda, Michio ^a   Ebihara, Ken ^a   Iwai, Hidenori ^a   Matsuoka, Naoki ^a   Satoh, Noriko ^a   Odaka, Hiroyuki ^b   Kasuga, Hisao ^b   Fujisawa, Yukio ^b   Inoue, Gen ^a   Nishimura, Haruo ^a   Yoshimasa, Yasunao ^a   Nakao, Kazuwa ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TAKEDA PHARMACEUTICAL COMPANY LIMITED   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOGEN; INSULIN; LEPTIN; LIPID;

ADOLESCENT; ANIMAL TISSUE; ARTICLE; FEMALE; GENE OVEREXPRESSION; GLUCOSE METABOLISM; GLUCOSE UTILIZATION; GLYCOGEN METABOLISM; INSULIN SENSITIVITY; LIPID STORAGE; LIVER; MALE; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; SKELETAL MUSCLE; TRANSGENIC MOUSE;

ANIMALS; BODY WEIGHT; FEMALE; GLUCOSE; INSULIN RESISTANCE; LEPTIN; LIPID METABOLISM; LIVER; LIVER GLYCOGEN; MALE; MICE; MICE, TRANSGENIC; OBESITY; PROTEIN BIOSYNTHESIS; SIGNAL TRANSDUCTION;

EID: 0032848779     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.48.9.1822     Document Type: Article

References (44)

1. Spiegelman BM, Flier JS: Adipogenesis and obesity: rounding out the big picture. Cell 87:377-389, 1996
2. Reaven GM: The fourth musketeer from Alexandre Dumas to Claude Bernard. Diabetologia 38:3-13, 1995
3. Ailhaud G, Grimaldi P, Negrel R: Cellular and molecular aspects of adipose tissue development Annu Rev Nutr 12:207-233, 1992
4. Friedman JM, Halaas JL: Leptin and the regulation of body weight in mammals. Nature 395:763-770, 1968
5. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM: Positional cloning of the mouse obese gene and its human homologue. Nature 372:425-432, 1994
6. Ogawa Y, Masuzaki H, Isse N, Okazaki T, Mori K, Shigemoto M, Satoh N, Tamura N, Hosoda K, Yoshimasa Y, Jingami H, Kawada T, Nakao K: Molecular cloning of rat obese cDNA and augmented gene expression in genetically obese Zucker fatty (fa/fa) rats. J Clin Invest 96:1647-1652, 1995
7. Pelleymounter MA, Cullen MJ, Bake MBR, Hecht R, Winters D, Boone T, Collins F: Effects of the obese gene product on body weight regulation in ob/ob mice. Science 269:540-543, 1995
8. Halaas JL, Gajiwata KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D, Lallone RL, Burley SK, Friedman JM: Weight-reducing effects of the plasma protein encoded by the obese gene. Science 269:543-546, 1995
9. Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P: Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 269:546-549, 1995
10. Tartaglia LA, Dembski M, Weng X, Deng N, Culpepper J, Devos R, Richards GJ, Campfield LA, Clark FT, Deeds J, Muir C, Sanker S, Moriarty A, Moore KJ, Smutko JS, Mays GG, Woolf EA, Monroe CA, Tepper RI: Identification and expression cloning of a leptin receptor, OB-R. Cell 83:1263-1271, 1995
11. Kamohara S, Burcelin R, Halaas JL, Friedman JM, Charron MJ: Acute stimulation of glucose metabolism in mice by leptin treatment Nature 389:374-377, 1997
12. Liu L, Karkanias GB, Morales JC, Hawkins M, Barzilai N, Wang J, Rossetti L: Intracerebroventricular leptin regulates hepatic but not peripheral glucose fluxes. J Biol Chem 273:31160-31167, 1998
13. Cusin I, Zakrzewska KE, Boss O, Mizzin P, Giacobino J-P, Ricquier D, Jeanrenaud B, Rohner-Jeanrenaud F: Chronic central leptin infusion enhances insulin-stimulated glucose metabolism and favors the expression of uncoupling proteins. Diabetes 47:1014-1019, 1998
14. Shi ZQ, Nelson A, Whitcomb L, Wang J, Cohen AM: Intracerebroventricular administration of leptin markedly enhances insulin sensitivity and systemic glucose utilization in conscious rats. Metabolism 47:1274-1280, 1998
15. Siegrist-Kaiser CA, Pauli V, Juge-Aubry CE, Boss O, Pernin A, Chin WW, Cusin I, Rohner-Jeanrenaud F, Burger AG, Zapf J, Meier C: Direct effects of leptin on brown and white adipose tissue. J Clin Invest 100:2858-2864, 1997
16. Shimabukuro M, Koyama K, Chen G, Wang M-Y, Trieu F, Lee Y, Newgard CB, Unger RH: Direct antidiabetic effect of leptin through triglyceride depletion of tissues. Proc Natl Acad Sci USA 94:4637-4641, 1997
17. Muoio DM, Dohn GL, Fiedorek FT Jr, Tapscott EB, Coleman RA: Leptin directly alters lipid partitioning in skeletal muscle. Diabetes 46:1360-1363, 1997
18. Aiston S, Agius L: Leptin enhances glycogen storage in hepatocytes by inhibition of phosphorylase and exerts an additive effect with insulin. Diabetes 48:15-20, 1999
19. Emilsson V, Liu Y-L, Cawthrone MA, Morton NM, Davenport M: Expression of the functional leptin receptor mRNA in pancreatic islets and direct inhibitory action of leptin on insulin secretion. Diabetes 46:313-316, 1997
20. Frederich RC, Hamann A, Anderson S, Lollmann B, Lowell BB, Flier JS: Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action. Nature Med 1:1311-1314, 1995
21. Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, Fei H, Kim S, Lallone R, Ranganathan S, Kern PA, Friedman JM: Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nature Med 1:1155-1161, 1995
22. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, Mckee LJ, Buer TL, Caro JF: Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 334:292-295, 1996
23. Hosoda K, Masuzaki H, Ogawa Y, Miyawaki T, Hiraoka J, Hanaoka I, Yasuno A, Nomura T, Fujisawa Y, Yoshimasa Y, Nishi S, Yamori Y, Nakao K: Development of radioimmunoassay for human leptin. Biochem Biophys Res Commun 221:234-239, 1996
24. Grinspoon S, Gulick T, Askari H, Landt M, Lee K, Anderson E, Ma Z, Vignati L, Bowsher R, Herzog D, Klibanski A: Serum leptin levels in women with anorexia nervosa. J Clin Endocrinol Metab 75:358-361, 1996
25. Pardini VC, Victoria IM, Rocha SM, Andrade DG, Rocha AM, Pieroni FB, Milagres G, Purisch S, Velho G: Leptin levels, β-cell function, and insulin sensitivity in families with congenital and acquired generalized lipoatrophic diabetes. J Clin Endocrinol Metab 83:503-508, 1998
26. Ogawa Y, Itoh H, Tamura N, Suga S, Yoshimasa T, Uehira M, Matsuda S, Shiono S, Nishimoto H, Nakao K: Molecular cloning of the complementary DNA and gene that encode mouse brain natriuretic peptide and generation of transgenic mice that overexpress the brain natriuretic peptide gene. J Clin Invest 93:1911-1921, 1994
27. Suda M, Ogawa Y, Tanaka K, Tamura N, Yasoda, A, Takigawa T, Uehira M, Nishimoto H, Itoh H, Saito Y, Shiota K, Nakao K: Skeletal overgrowth in transgenic mice that overexpress brain natriuretic peptide. Proc Natl Acad Sci USA 106:2337-2347, 1998
28. Terauchi Y, Iwamoto K, Tamemoto H, Komeda K, Ishii C, Kanazawa Y, Asanuma N, Aizawa T, Akanuma Y, Yasuda K, Kodama T, Tobe K, Yazaki Y, Kadowaki T: Development of non-insulin-dependent diabetes mellitus in the double knockout mice with disruption of insulin receptor substrate-1 and β cell glucokinase genes: genetic reconstitution of diabetes as a polygenic disease. J Clin Invest 99:861-866, 1997
29. Suga J, Yoshimasa Y, Yamada K, Yamamoto Y, Inoue G, Okamoto M, Hayashi T, Shigemoto M, Kosaki A, Kuzuya H, Nakao K: Differential activation of mitogen-activated protein kinase by insulin and epidermal growth factor in 3T3-L1 adipocytes: a possible involvement of PI3-kinase in the activation of the MAP kinase by insulin. Diabetes 46:735-741, 1997
30. Folli F, Saad MJA, Backer JM, Kahn CR: Regulation of phosphatidylinositol 3-kinase activity in liver and muscle of animal models of insulin-resistant and insulin-dependent diabetes mellitus. J Clin Invest 92:1787-1794, 1997
31. Ioffe E, Moon B, Connolly E, Friedman JM: Abnormal regulation of the leptin gene in the pathogenesis of obesity. Proc Natl Acad U S A 95: 11852-11857, 1998
32. Bray G, Bouchard C: Genetics of human obesity: research directions. FASEB J 11:937-945, 1997
33. Burant CF, Sreenan S, Hirano K, Tai T-AC, Lohmiller J, Lukens J, Davidson NO, Ross S, Graves RA: Troglitazone action is independent of adipose tissue. J Clin Invest 100:2900-2908, 1997
34. Moitra J, Mason MM, Olive M, Krylov D, Gavrilova O, Macus-Samuels B, Feigenbaum L, Lee E, Aoyama T, Eckhaus M, Reitman ML, Vinson C: Life without white fat: a transgenic mouse. Genes Dev 12:3168-3181, 1998
35. Shimomura I, Hammer RE, Richardson JA, Ikemoto S, Bashmakov Y, Goldstein JL, Brown MS: Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized lipodystrophy. Genes Dev 12:3182-3194, 1998
36. Gallen IW, MacDonald IA, Allison SP: Glucose metabolism and thermogenesis during glucose and insulin infusion in severely underweight patients. J Parenter Enteral Nutr 16:5-10, 1992
37. Hotamisligil G, Spiegelman BM: Tumor necrosis factor α: a key component of the obesity-diabetes link. Diabetes 43:1271-1278, 1994
38. Goldstein BJ: Syndrome of extreme insulin resistance. In Joslin's Diabetes Mellitus. 13th ed. Kahn CR, Weir GC, Eds. Philadelphia, Lea & Febiger, 1994, p. 282-299
39. Halaas JL, Boozer C, Blair-West J, Fidahusein N, Denton DA, Friedman JM: Physiological response to long-term peripheral and central leptin infusion in lean and obese mice. Proc Natl Acad Sci USA 94:8878-8883, 1997
40. Chen G, Koyama K, Yuan X, Lee Y, Zhou Y-T, O'Doherty R, Newgard CB, Unger RH: Disappearance of body fat in normal rats induced by adenovirus-mediated leptin gene therapy. Proc Natl Acad Sci U S A 93:14795-14799, 1996
41. Muzzin P, Eisensmith RC, Copeland KC, Woo SLC: Correction of obesity and diabetes in genetically obese mice by leptin gene therapy. Proc Natl Acad Sci U S A 93:14804-14808, 1996
42. Boston BA, Blaydon KM, Varnerin J, Cone RD: Independent and additive effects of central POMC and leptin pathways on murine obesity. Science 278:1641-1644, 1997
43. Caro JF, Kolaczynski JW, Nyce MR, Ohanenesian JP, Opentanova I, Goldman WH, Lynn RB, Zhang PI, Sinha MK, Considine RV: Decreased cerebrospinalfluid/serum leptin ratio in obesity: a possible mechanism for leptin resistance. Lancet 348:159-161, 1996
44. Schwartz MW, Peskind E, Raskind M, Boyko EJ, Porte R Jr. Cerebrospinal fluid leptin levels: relationship to plasma levels and to adiposity in humans. Nature Med 2:589-593, 1996